MC

Meghana C Dixit

Active Director Director DIN 09404342
DIN 09404342 First appointment Nov 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Meghana C Dixit

Data last updated:

Meghana C Dixit is a Director at Chanre Rheumatology And Immunology Center And Research Private Limited (since 2021). The company operates in Healthcare. Chanre Rheumatology And Immunology Center And Research Private Limited reported revenue of ₹14.17 Cr (FY 2025).

DIN 09404342
Primary Designation Director
Industry Healthcare
First Appointment 18 Nov 2021
Oldest Company Age 19 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Nov 20212007₹14.17 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Chanre Rheumatology And Immunology Center And Research Private Limited
Premium access

Shareholding and investment profile for Meghana C Dixit

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meghana C Dixit

Meghana C Dixit currently holds 1 directorship: Chanre Rheumatology And Immunology Center And Research Private Limited (Director, since 18 Nov 2021, revenue ₹14.17 Cr (FY 2025)).

Meghana C Dixit was first appointed on 18 Nov 2021 as Director at Chanre Rheumatology And Immunology Center And Research Private Limited.

The current boards of Meghana C Dixit's companies include Manasa Chandrashekara Dixit (Chanre Rheumatology And Immunology Center And Research Private Limited), Renuka Chandrasekhar (Chanre Rheumatology And Immunology Center And Research Private Limited), Srikantiah Chandrashekara (Chanre Rheumatology And Immunology Center And Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available